HomeFileCoronary disease

Coronary disease

SOLACI-SBHCI 2023 | Imaging is key to initial procedural strategy: getting it right first time – Dr. Janar Sathananthan

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Janar...

SOLACI-SBHCI 2023 | How to reduce mortality with cardiogenic shock? – Dr. George Dangas

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. George...

Long Term Outcomes after Complex PCI According to Operator Experience and Use of IVUS

The use of intravascular ultrasound (IVUS) to guide percutaneous coronary interventions (PCI) has been shown to reduce...

Crisis and Socioeconomic Disparities: Relationship with Recurrent Events After Myocardial Infarction

Socioeconomic status (SES) has been linked to recurrent atherosclerotic cardiovascular disease events (rASCVD) after myocardial infarction (MI)....

Are There Sex Differences in pLVAD-Assisted High Risk PCI?

The proportion of patients undergoing high risk PCI (HRPCI) is on the rise. It includes patients with...

EuroCTO: Safety and Benefit at 3 Years

Chronic total occlusions (CTOs) account for approximately 15-20% of patients with stable coronary artery disease. This field...

STREAM-2: Reduced Dosage of Tenecteplase for Patients over 60 Years Old

Reduced dosage of tenecteplase in elderly patients undergoing a pharmaco-invasive strategy. Delays in achieving timely reperfusion in patients...

ABSORB IV – Improving Bioresorbable Scaffolds: A Long Road

5-year followup of bioresorbable scaffolds in selected and better prepared lesions (ABSORB IV).  Historically, when comparing previously used...